737 citations
,
August 2020 in “Journal of Infection” This study found that most patients hospitalized for COVID-19 experienced persistent symptoms over 100 days post-admission, with no significant difference in symptoms between those treated in regular wards and intensive care units.
56 citations
,
May 2021 in “Journal of infection/The Journal of infection” This study found that 80% of hospitalized COVID-19 survivors experienced at least one post-COVID symptom seven months after discharge, with fatigue, hair loss, and dyspnea being the most common.
September 2022 in “Journal of The American Academy of Dermatology” This review summarizes existing literature on COVID-19-associated alopecia, finding that androgenic alopecia may increase COVID-19 risk, while telogen effluvium often follows infection.
8 citations
,
January 2022 in “Cureus” This case study reports a patient with post-COVID-19 diffuse alopecia who experienced gradual hair recovery to near pre-infection levels within seven months.
14 citations
,
February 2021 in “Open Forum Infectious Diseases” In this study, 84% of postacute COVID-19 patients experienced at least one persistent symptom 60 days after hospital discharge, regardless of initial disease severity.